About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Migraine Clinical Trials in Philadelphia | 144 Studies

Clinical Trials MigrainePhiladelphia

Migraine Clinical Trials in Philadelphia

Find 144 clinical trials for migraine near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Migraine trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 144 trials

CompletedOccipital Blocks for Acute MigraineMigraine affects 10-28% of children and adolescents and yet 20-30% of patients are ineffectively treated with current oral and nasal options.NCT03526874·Philadelphia, Pennsylvania CompletedEvaluation of a Novel Device for Treatment of Migraine HeadacheMigraine is a common neurologic with attacks of headache and associated symptoms such as nausea, vomiting, phono and photophobia.NCT03361423·Hartford, Connecticut and 11 others

Migraine Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedTreatment for Migraines With an Implantable DeviceThe purpose of this study is to evaluate the safety and effectiveness of an implantable device for difficult to treat migraine.NCT00286078·Denver, Colorado and 14 others

TerminatedOccipital Nerve Stimulation in the Treatment of MigraineThe objective of this proof-of-concept study is to generate initial safety and effectiveness data for the neuro-modulation stimulation (NMS) E-Box in patients with chronic…NCT01855672·Newington, New Hampshire and 3 others

Enrolling by invitationLong-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to…NCT05127954·Huntsville, Alabama and 112 others

CompletedRandomized Trial in Adult Participants With Acute MigrainesThe purpose of this study is to test the safety and efficacy of BHV-3500 (zavegepant) versus placebo in the acute treatment of moderate or severe migraine.NCT04571060·Huntsville, Alabama and 93 others

CompletedDFN-02 Open Label Safety Study in Patients With Acute MigraineA multi-center, open-label, safety study of DFN-02 for the Treatment of Acute MigrainesNCT02279082·Phoenix, Arizona and 23 others

CompletedAssessment of LBR-101 In Chronic MigraineThe purpose of the study is to determine whether monthly subcutaneous administration of LBR-101 (fremanezumab) is safe and provides migraine prevention in patients with chronic…NCT02021773·Gilbert, Arizona and 56 others

CompletedOccipital Nerve Stimulation for the Treatment of Chronic Migraine Headache.Background: Medically intractable chronic migraine (CM) is a disabling illness characterized by headache greater than 15 days per month.NCT00200109·Scottsdale, Arizona and 8 others

CompletedStudy to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine PreventionTo evaluate the effect of erenumab compared to placebo on the change from baseline in monthly migraine days, in adults with episodic migraine.NCT02483585·Birmingham, Alabama and 75 others

RecruitingMMA Embolization for Refractory Chronic MigraineThis is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA)…NCT06735833·Walnut Creek, California and 7 others

CompletedEvaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of MigraineThe purpose of the study is to evaluate the treatment satisfaction of subjects using Sumavel DosePro to treat their moderate to severe migraines.NCT01016834·Birmingham, Alabama and 20 others

CompletedStudy of Sustained Benefit of AMG334 in Adult Episodic Migraine PatientsThe purpose of this study is to compare the sustained long-term benefit between two treatment paradigms of migraine prophylactic agents (erenumab versus a control arm of oral…NCT03927144·Stanford, California and 111 others

CompletedComparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic MigraineThe study is being conducted to evaluate two doses of TEV-48125 in adult patients with chronic migraineNCT02621931·Birmingham, Alabama and 272 others

TerminatedPArtial REbreathing for Migraine With Aura 1A prospective, multi-centre, randomized, double-blind, sham-controlled, parallel-group, group-sequential study to investigate safety and effectiveness of the Rehaler partial…NCT05546385·Palo Alto, California and 14 others

CompletedAn Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve MonthsThis study will use an open-label design to evaluate the safety of NP101.NCT00806546·Phoenix, Arizona and 30 others

TerminatedExtension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine PreventionThis Phase 2 Extension trial will evaluate the efficacy and safety of ABP-450 for migraine prevention in adults who suffer from six or more migraine days per month.NCT05016661·Chandler, Arizona and 54 others

CompletedA Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of MigraineThis is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep as compared to placebo in the acute treatment of migraine.NCT06848075·Birmingham, Alabama and 65 others

CompletedStudy of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic MigraineMigraine is characterized by attacks of throbbing, moderate or severe headache, often associated with nausea, vomiting, and/or sensitivity to light and/or sound.NCT05216263·Hoover, Alabama and 28 others

Active not recruitingA Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in AdultsA migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head.NCT06625060·Birmingham, Alabama and 161 others

PreviousPage 7 of 8Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia